Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 49,331 |
|
|||||
| News | - | ||||||
| Day High | 1.4754 | Low High |
|||||
| Day Low | 1.3801 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Imunon Inc | IMNN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0655 | 4.55% | 1.5055 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.45 | 1.3801 | 1.4754 | 1.44 | 1.44 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 291 | 49,331 | $ 1.44 | $ 70,886 | - | 0.48 - 2.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:39:09 | 50 | $ 1.49 | USD |
Imunon Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 18.42M | 9.40M | - | 0 | -19.52M | -2.08 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Imunon News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IMNN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.09 | 1.4754 | 1.09 | 1.29 | 62,090 | 0.4155 | 38.12% |
| 1 Month | 1.67 | 1.95 | 1.04 | 1.59 | 210,533 | -0.1645 | -9.85% |
| 3 Months | 0.5677 | 2.00 | 0.48 | 1.22 | 232,600 | 0.9378 | 165.19% |
| 6 Months | 0.9883 | 2.00 | 0.48 | 1.13 | 134,374 | 0.5172 | 52.33% |
| 1 Year | 1.12 | 2.00 | 0.48 | 1.14 | 79,983 | 0.3855 | 34.42% |
| 3 Years | 1.96 | 2.00 | 0.48 | 1.24 | 71,266 | -0.4545 | -23.19% |
| 5 Years | 1.96 | 2.00 | 0.48 | 1.24 | 71,266 | -0.4545 | -23.19% |
Imunon Description
| Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. |
